Mohamed Abdelbaky | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Mohamed Abdelbaky | Pharmaceutical Science | Best Researcher Award

Professor-Biochemistry from Avalon Medical School, Curaçao

Dr. Mohamed Fakhry Mohamed Abdelbaky is a distinguished professor of biochemistry with a robust academic and research background spanning over two decades. He earned his PhD in Biochemistry from Glasgow Caledonian University, UK, in 2011, following his MSc and MB.B.Ch from Minya University, Egypt. Dr. Abdelbaky has held significant academic positions across various international institutions, including Avalon University School of Medicine in Curaçao, Texila American University in Guyana, and Al Maarefa University in Saudi Arabia. His roles have encompassed curriculum development, teaching, student evaluation, and administrative leadership. His research interests are diverse, focusing on molecular biology, cancer research, and pharmacological studies, with numerous publications in reputable journals. Dr. Abdelbaky’s commitment to education and research excellence is evident through his active participation in academic committees, mentorship, and continuous professional development. His contributions have significantly advanced the field of biochemistry, making him a valuable asset to the scientific community.

Professional Profile

Education

Dr. Abdelbaky’s educational journey reflects a strong foundation in medical and biochemical sciences. He obtained his Bachelor of Medicine and Surgery (MB.B.Ch) from the Faculty of Medicine, Minya University, Egypt, in 2000. Pursuing his passion for biochemistry, he completed his Master of Science (MSc) in Biochemistry at the same institution in 2006, where his thesis focused on the effects of plasma homocysteine on VEGF levels in platelets and neutrophils. To further enhance his expertise, he pursued a PhD in Biochemistry and Molecular Biology at Glasgow Caledonian University, UK, completing it in 2011. His doctoral research investigated the biological effects of the proto-oncoprotein EVI1 in normal and transformed fibroblasts. This comprehensive educational background has equipped Dr. Abdelbaky with the knowledge and skills necessary to excel in both academic and research settings, contributing significantly to the field of biochemistry.

Professional Experience

Dr. Abdelbaky’s professional career is marked by a series of progressive academic appointments and responsibilities. He began as a Teaching Assistant at Minya University, Egypt, where he was involved in designing and supervising laboratory experiments for medical students. His dedication led to his promotion to Assistant Lecturer and subsequently to Lecturer, where he continued to contribute to teaching and research activities. He expanded his international experience by serving as a Postgraduate Demonstrator at Glasgow Caledonian University, UK, where he supervised laboratory sessions and research projects for science students. Dr. Abdelbaky furthered his academic career as an Assistant Professor at Al Maarefa University in Saudi Arabia, teaching medical biochemistry and genetics to students of various health science programs. He later joined Texila American University in Guyana as an Associate Professor, where he was responsible for curriculum design and delivery of biochemistry and medical genetics courses. Currently, he holds the position of Professor at Avalon University School of Medicine in Curaçao, where he continues to contribute to curriculum development, teaching, and student mentorship. Throughout his career, Dr. Abdelbaky has demonstrated a commitment to academic excellence and leadership in biochemistry education.

Research Interests

Dr. Abdelbaky’s research interests are centered around molecular biology, cancer research, and pharmacological studies. He has a particular focus on understanding the molecular mechanisms underlying various diseases, including cancer and metabolic disorders. His research explores the roles of specific genes and proteins in disease progression and treatment responses. Dr. Abdelbaky is also interested in the development and evaluation of pharmacological agents for disease prevention and therapy. His work often involves investigating the effects of natural compounds and pharmaceuticals on cellular and molecular pathways. Through his research, Dr. Abdelbaky aims to contribute to the development of effective diagnostic and therapeutic strategies for complex diseases, ultimately improving patient outcomes.

Research Skills

Dr. Abdelbaky possesses a comprehensive set of research skills that enable him to conduct advanced studies in biochemistry and molecular biology. He is proficient in tissue culture techniques, allowing for the cultivation and maintenance of various cell lines for experimental purposes. His expertise includes the isolation of DNA, RNA, and proteins, essential for analyzing gene and protein expression. Dr. Abdelbaky is skilled in polymerase chain reaction (PCR) and reverse transcription PCR (RT-PCR), techniques crucial for amplifying and studying specific DNA and RNA sequences. He is experienced in gene knockdown methods, which are used to study gene function by reducing gene expression. Additionally, he is adept at performing agarose and polyacrylamide gel electrophoresis (PAGE) for the separation and analysis of nucleic acids and proteins. These technical skills are fundamental to his research endeavors, enabling him to investigate complex biological processes and contribute valuable insights to the field of biochemistry.

Awards and Honors

Throughout his career, Dr. Abdelbaky has received recognition for his contributions to biochemistry and medical education. He is a member of several prestigious professional societies, including the Academy of Medical Educators (AoME) in the UK, the Egyptian Medical Syndicate, and the Egyptian Society of Medical Biochemistry. His active participation in these organizations reflects his commitment to professional development and collaboration within the scientific community. Dr. Abdelbaky has also contributed to the peer-review process for scientific journals, demonstrating his expertise and dedication to maintaining high standards in research publication. His involvement in continuous medical education (CME) programs and attendance at international conferences further highlight his pursuit of knowledge and excellence in his field. These accolades and affiliations underscore Dr. Abdelbaky’s standing as a respected figure in biochemistry and medical education.

Conclusion

Dr. Mohamed Fakhry Mohamed Abdelbaky’s extensive academic background, international teaching experience, and robust research portfolio position him as a leading figure in the field of biochemistry. His dedication to education is evident through his curriculum development efforts, mentorship, and active participation in academic committees. His research contributions have advanced the understanding of molecular mechanisms in disease and informed the development of therapeutic strategies. Dr. Abdelbaky’s technical expertise and commitment to professional growth have earned him recognition within the scientific community. His multifaceted career reflects a blend of academic excellence, research innovation, and leadership, making him a valuable asset to any institution and a strong candidate for accolades such as the Best Researcher Award.

Publications Top Notes

  1. Title: Enhanced sensitivity to hydrogen peroxide-induced apoptosis in Evi1 transformed Rat1 fibroblasts due to repression of carbonic anhydrase III
    Authors: Roy P, Reavey E, Rayne M, Roy S, Abed El Baky M, Ishii Y, Bartholomew C
    Year: 2010

  2. Title: BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
    Authors: Roy S, Jørgensen HG, Roy P, Abed El Baky M, Melo JV, Strathdee G, Holyoake TL, Bartholomew C
    Year: 2012

  3. Title: Potential impact of urocortin I on sperm count, motility and sex hormone profiles in normal adult rats
    Authors: Hany A. El Kattawy, Mahmoud A. Naga, Ahmed Shata, Mohamed A. Elbaky
    Year: 2016

  4. Title: PTEN/PI3K/VEGF signaling pathway involved in the protective effect of xanthine oxidase inhibitor febuxostat against endometrial hyperplasia in rats
    Authors: MZ Mohamed, MF Abed El Baky, OA Hassan, HH Mohammed, AM Abdel-Aziz
    Year: 2020

  5. Title: The relation between ACKR4 and CCR7 genes expression and breast cancer metastasis
    Authors: Mostafa M. Mohammed, Olfat Shaker, Maggie M. Ramzy, Shereen S. Gaber, Heba S. Kamel, Mohamed F. Abed EL Baky
    Year: 2021

  6. Title: Aprepitant exerts anti-fibrotic effect via inhibition of TGF-β/Smad3 pathway in bleomycin-induced pulmonary fibrosis in rats
    Authors: Mervat Z. Mohamed, Mohamed F. Abed El Baky, Merhan E. Ali, Heba M. Hafez
    Year: 2022

  7. Title: Mirabegron alleviates acetic acid-induced colitis in rats: role of adiponectin and GSTM1/GSH detoxification pathway
    Authors: Mervat Z. Mohamed, Mohamed F. Abed El Baky, Sahar A. Mokhemer, Heba M. Hafez
    Year: 2023

  8. Title: Cardioprotective effect of Ginger in a rat model of myocardial damage and its possible intervention in PERK-ATF4-CHOP-PUMA apoptotic pathway
    Authors: M. M. Mohammed, N. A. A. Osman, F. M. Moura, M. F. Abedelbaky
    Year: 2023

  9. Title: Vinpocetine alleviates valproic acid-induced hepatotoxicity and neurotoxicity through activation of cAMP and PI3K/AKT/CREB pathway in rats
    Authors: Heba M. Hafez, Mohamed F. Abed El Baky, Sahar A. Mokhemer, Salma M. Hassan, Mervat Z. Mohamed
    Year: Under submission (anticipated 2024 or 2025)

Yongpan An | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr. Yongpan An | Pharmaceutical Science | Best Researcher Award

Pharmacology Researcher from Xi’an People’s Hospital (Xi’an Fourth Hospital), China

Yongpan An is an emerging researcher in the field of pharmacology, specializing in drug screening and the mechanistic study of aging and aging-related diseases. A recent Ph.D. graduate from Peking University, Dr. An has demonstrated significant promise through his contributions to high-impact research, authoring and co-authoring several peer-reviewed publications. His work spans various disciplines, including molecular biology, artificial intelligence, and pharmacological intervention, reflecting a multidisciplinary approach essential for innovative biomedical research. As of now, he is affiliated with Xi’an People’s Hospital, where he continues to build on his doctoral research. Dr. An has already co-authored influential studies published in journals such as Nature Biotechnology, Aging Cell, Frontiers in Pharmacology, and Life Medicine. Despite being early in his career, his scientific output, collaboration with renowned researchers, and peer review responsibilities signal a strong foundation for a successful academic trajectory. His research addresses a critical area in medical science—aging—and aims to identify compounds that can prolong lifespan and reduce age-associated degeneration. With demonstrated leadership in co-authorship roles and contributions to the understanding of pharmacological interventions for aging, Yongpan An stands out as a dedicated, capable, and innovative young scientist poised for further accomplishments.

Professional Profile

Education

Yongpan An’s academic journey reflects a solid foundation in biotechnology and pharmacology, cultivated through rigorous training at leading Chinese institutions. He began his undergraduate studies in Biotechnology at Yunnan University, where he developed fundamental skills in molecular biology and biochemical research. From 2014 to 2018, he was immersed in coursework and research that exposed him to laboratory techniques and foundational knowledge in life sciences. His pursuit of advanced studies led him to Peking University, one of China’s most prestigious academic institutions, where he obtained his Ph.D. in Pharmacology between 2018 and 2023. At Peking University, under the mentorship of Dr. Zhengwei Xie, he focused on drug screening and the molecular mechanisms underlying aging. During this period, Dr. An gained hands-on experience with advanced pharmacological methodologies, contributing to several high-impact studies. His doctoral training not only equipped him with scientific expertise but also fostered skills in critical thinking, interdisciplinary collaboration, and scientific communication. His research incorporated cutting-edge areas such as the application of artificial intelligence in drug discovery, reinforcing the modern relevance of his education. This academic progression—from biotechnology to pharmacology—provides a robust framework for his current and future research endeavors in aging and age-related diseases.

Professional Experience

Dr. Yongpan An is currently employed at Xi’an People’s Hospital, where he continues to engage in pharmacological research with a focus on aging and age-related diseases. Although early in his professional career, Dr. An has already demonstrated remarkable productivity and leadership in scientific research. During his doctoral studies at Peking University, he was deeply involved in collaborative projects that combined pharmacological experimentation with computational analysis. His work involved both in vivo and in vitro models, providing him with experience across various experimental platforms. In addition to research responsibilities, Dr. An served as a reviewer for the journal Pharmacological Research, evaluating scientific manuscripts and gaining familiarity with the editorial and peer-review process. His professional engagements have also included active participation in scientific conferences and forums, where he presented his findings and interacted with experts in the field of aging and pharmacology. Notably, he played a major role in authoring a comprehensive review titled The Landscape of Aging, where he was responsible for summarizing the application of artificial intelligence in anti-aging drug discovery. As he transitions from a student to an independent researcher, Dr. An continues to demonstrate commitment to excellence, innovation, and scientific rigor in his ongoing professional endeavors.

Research Interests

Dr. Yongpan An’s primary research interests lie in the pharmacological modulation of aging and the discovery of novel compounds targeting aging-related diseases. His work integrates drug screening techniques with the mechanistic study of cellular and organismal aging processes. Specifically, he is interested in understanding how small molecules interact with key molecular pathways, such as the AKT signaling cascade, p16, and cyclin regulatory mechanisms, to delay senescence and promote healthy lifespan extension. Another key area of interest for Dr. An is the use of natural products, such as oridonin and berberine, in regulating cellular aging. His contributions to this field are evident from his publications in high-impact journals that explore the therapeutic potential of such compounds in mouse and yeast models. Additionally, he has contributed to the development of AI-driven tools for predicting drug efficacy from transcriptional profiles, showcasing his interest in computational pharmacology. The integration of artificial intelligence and deep learning with experimental pharmacology highlights his vision of combining traditional experimental approaches with cutting-edge digital methodologies. His overarching goal is to discover and validate compounds that not only extend lifespan but also improve quality of life by mitigating the effects of chronic and degenerative diseases associated with aging.

Research Skills

Dr. Yongpan An possesses a diverse and interdisciplinary set of research skills, developed through years of academic training and hands-on laboratory experience. He is proficient in a wide range of pharmacological and molecular biology techniques, including cell culture, Western blotting, immunofluorescence, RNA extraction, and quantitative PCR. He has extensive experience working with animal models, especially in the context of lifespan and senescence studies in mice and yeast, which are central to his research in aging. His capabilities also include the screening and identification of bioactive compounds using high-throughput methods, allowing him to evaluate the pharmacodynamic and pharmacokinetic properties of candidate molecules. Dr. An is adept at using bioinformatics and artificial intelligence tools to analyze gene expression data and predict drug responses. This skillset was crucial in his involvement in the development of deep learning models for drug efficacy prediction, published in Nature Biotechnology. Moreover, his experience as a peer reviewer reflects his ability to critically assess scientific literature and evaluate experimental design, data quality, and interpretation. His collaborative skills and familiarity with interdisciplinary projects further enhance his research capabilities, making him an asset to both academic and clinical research teams focusing on anti-aging pharmacological interventions.

Awards and Honors

Despite being at the beginning of his career, Dr. Yongpan An has already received several prestigious awards in recognition of his academic excellence and research achievements. During his doctoral studies at Peking University, he was honored with the National Scholarship, a highly competitive award given to outstanding students in China. He also received the First Prize in the Soaring Young Scholar competition held by Northwestern Polytechnical University, which recognizes young researchers for innovative scientific contributions. Additionally, he was awarded the Second Prize at the Young Scientist Forum Report organized by the Beijing Society of Pharmacology and Physiological Sciences, affirming his potential as a promising figure in pharmacological research. These honors not only reflect his dedication to scientific inquiry but also underscore the impact and relevance of his work within the research community. His involvement as a co-first author in significant collaborative publications further demonstrates peer recognition of his scholarly efforts. Beyond awards, his service as a manuscript reviewer for an established journal like Pharmacological Research highlights the trust placed in his scientific judgment. Collectively, these accolades validate Dr. An’s emerging role as a capable and committed young scientist with a promising future in pharmacology and aging research.

Conclusion

In summary, Dr. Yongpan An embodies the qualities of a highly promising early-career researcher with a strong academic foundation, impactful research output, and growing recognition within the scientific community. His work focuses on one of the most critical areas in medical science—understanding and intervening in the aging process to improve human health and longevity. His background in both experimental pharmacology and artificial intelligence places him at the intersection of innovation and translational medicine. Despite his relatively recent graduation, he has already authored multiple first-author publications, participated in high-level collaborative research, and received awards for his contributions. Dr. An’s dedication to advancing the pharmacological understanding of aging-related diseases and his proactive engagement in academic publishing and peer review highlight his scientific maturity. He is currently well-positioned to expand his research, attract future funding, and lead independent projects that will further enhance his professional profile. As he continues to build his research portfolio at Xi’an People’s Hospital, Dr. An is likely to contribute significantly to the development of therapeutic strategies that target aging and its associated disorders. Therefore, he represents an outstanding candidate for recognition through awards that honor excellence in scientific research.

Publications Top Notes

  1. Title: Genetically modified extracellular vesicles loaded with activated gasdermin D potentially inhibit prostate-specific membrane antigen-positive prostate carcinoma growth and enhance immunotherapy
    Authors: Gao, Ke; Xi, Wenjin; Ni, Jianxin; Zhang, Rui; Wu, Guojun
    Journal: Biomaterials
    Year: 2025

Carolina Batista | Pharmaceutical Science | Women Researcher Award

Posted on by ScienceFather

Dr. Carolina Batista | Pharmaceutical Science | Women Researcher Award

Biomedical from Federal University of Rio de Janeiro, Brazil

Dr. Carolina Batista is a distinguished global health physician with over two decades of experience in humanitarian and public health initiatives. Currently serving as the Head of Global Health Affairs at Baraka Impact Finance, she leverages her medical expertise and strategic insight to foster innovative health solutions for underserved populations. Her career commenced in Brazil, where she provided medical care to indigenous communities in the Amazon. In 2007, she joined Médecins Sans Frontières (MSF), undertaking assignments in Somalia, Africa, and Latin America, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. As Director of MSF’s Brazilian Medical Unit, she led international campaigns, notably for Chagas disease. Subsequently, at the Drugs for Neglected Diseases initiative (DNDi), she spearheaded access frameworks for NTDs across Latin America, influencing public policies and fostering partnerships. Dr. Batista holds a medical degree from Brazil and a master’s in International Public Health from institutions including the Swiss Tropical and Public Health Institute. Her contributions extend to roles on the International Board of MSF, The Lancet COVID-19 Commission, and as a strategic advisor for ISGlobal, reflecting her commitment to health equity and innovation in global health.

Professional Profile

Education

Dr. Carolina Batista’s educational journey is marked by a blend of clinical training and global public health expertise. She earned her medical degree in Brazil, grounding her in clinical practice and primary healthcare delivery. Pursuing a broader impact, she obtained a master’s degree in International Public Health through a collaborative program involving the Swiss Tropical and Public Health Institute, the Institute of Tropical Medicine in Antwerp, and the Royal Tropical Institute in Amsterdam. This multidisciplinary education equipped her with a comprehensive understanding of global health challenges, particularly in infectious and neglected diseases. Further enhancing her capabilities, Dr. Batista pursued advanced studies in management, health and human rights, and policy and advocacy from renowned institutions. This diverse educational background has been instrumental in her ability to design and implement effective health interventions and policies across various international contexts.

Professional Experience

Dr. Carolina Batista’s professional trajectory encompasses significant roles in global health organizations. Her career began in Brazil, providing medical care to indigenous communities in the Amazon. In 2007, she joined Médecins Sans Frontières (MSF), undertaking assignments in Somalia and later serving as Director of the Brazilian Medical Unit, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. She led international campaigns, notably for Chagas disease, and coordinated MSF’s medical response to COVID-19 in the Navajo Nation, USA. At the Drugs for Neglected Diseases initiative (DNDi), she served as Head of Access and Medical Affairs, developing access frameworks for NTDs across Latin America. Currently, as Head of Global Health Affairs at Baraka Impact Finance, she supports social entrepreneurs in developing innovative health solutions. Dr. Batista also holds positions on the International Board of MSF and serves as a strategic advisor for ISGlobal

Research Interests

Dr. Carolina Batista’s research interests are deeply rooted in global health equity, focusing on neglected tropical diseases (NTDs), health systems in low- and middle-income countries, and access to healthcare for vulnerable populations. She is particularly interested in the development and implementation of innovative financing mechanisms to achieve the Sustainable Development Goals (SDGs), the role of private capital in bridging healthcare access gaps, and the integration of ethical artificial intelligence in health communication. Her work also explores the intersection of migration and health, pandemic preparedness, and the gender gap in healthcare access. Dr. Batista’s research aims to inform policies and practices that enhance healthcare delivery and accessibility for marginalized communities worldwide.

Research Skills

Dr. Carolina Batista possesses a robust set of research skills that encompass both qualitative and quantitative methodologies. Her expertise includes treatment protocols, health systems analysis, diagnostics, and primary care, particularly concerning parasitic and neglected diseases. She is adept at designing and implementing operational research projects, developing access frameworks, and conducting policy analysis. Her skills extend to evaluating health programs, engaging with stakeholders, and advocating for policy changes. Dr. Batista’s proficiency in these areas enables her to contribute effectively to research initiatives aimed at improving health outcomes in underserved populations.

Awards and Honors

Dr. Carolina Batista’s contributions to global health have been recognized through various appointments and memberships. She serves on the International Board of Médecins Sans Frontières (MSF) and is a strategic advisor for the Barcelona Institute for Global Health (ISGlobal). Her role in leading MSF’s medical response to COVID-19 in the Navajo Nation and her involvement in The Lancet COVID-19 Commission underscore her commitment to addressing health crises. Additionally, she chairs the DNDi Latin America board and serves on the boards of The Lancet Migration Latin America, Movement Health Foundation, and Health in Harmony. These positions reflect her leadership and dedication to advancing health equity and innovation.

Conclusion

Dr. Carolina Batista exemplifies a career dedicated to advancing global health equity through clinical practice, research, and policy development. Her extensive experience with organizations like MSF and DNDi, coupled with her strategic role at Baraka Impact Finance, highlights her commitment to improving healthcare access for marginalized populations. Her educational background and research interests inform her holistic approach to health challenges, integrating innovative solutions with traditional practices. Dr. Batista’s leadership roles and board memberships further demonstrate her influence in shaping global health policies and initiatives. Her work continues to inspire and drive progress towards equitable healthcare worldwide.

Publications Top Notes

1. Exposed Subsoil Under Recovery for 30 Years: Influence of Management Strategies on Soil Physical Attributes and Organic Matter

  • Authors: Laura Silva Nantes, Carolina dos Santos Batista Bonini, Melissa Alexandre Santos, Lucas da Silva Alves, Josiane Lourencetti, Alfredo Bonini Neto, José Augusto Liberato de Souza, Gabriel Augusto da Silva Lunardelli, Mariana Bonini Silva, Dayara Vivian Alvares, et al.

  • Year: 2025

2. Accumulated Carbon Fractions in Tropical Sandy Soils and Their Effects on Fertility and Grain Yield in an Integrated Crop–Livestock System

  • Authors: Deyvison de Asevedo Soares, Bianca Midori Souza Sekiya, Viviane Cristina Modesto, Allan Hisashi Nakao, Leandro Alves Freitas, Isabela Malaquias Dalto de Souza, J.H.S. Luz, Fernando Shintate Galindo, Gelci Carlos Lupatini, Gustavo Pavan Mateus, et al.

  • Year: 2023

3. Evolution of Soil Chemical Fertility in an Area under Recovery for 30 Years with Anthropic Intervention

  • Authors: Josiane Lourencetti, Carolina dos Santos Batista Bonini, Marcelo Andreotti, Marlene Cristina Alves, Alfredo Bonini Neto, Melissa Alexandre Santos, Vitor Correa de Mattos Barretto, Roberth Wicleff Rodrigues de Figueredo

  • Year: 2023

4. Long-Term Integrated Systems of Green Manure and Pasture Significantly Recover the Macrofauna of Degraded Soil in the Brazilian Savannah

  • Authors: Carolina dos Santos Batista Bonini, Thais Monique de Souza Maciel, Bruno Rafael de Almeida Moreira, José Guilherme Marques Chitero, Rodney Lúcio Pinheiro Henrique, Marlene Cristina Alves

  • Year: 2023

5. Long-Term Integrated Crop–Livestock–Forestry Systems Recover the Structural Quality of Ultisol Soil

  • Authors: Aline Matos, Carolina dos Santos Batista Bonini, Bruno Rafael de Almeida Moreira, Marcelo Andreotti, Reges Heinrichs, Diogo Tiago da Silva, José Augusto Liberato de Souza, Melissa Alexandre Santos, Cristiana Andrighetto, Gustavo Mateus Pavan, et al.

  • Year: 2022

6. Azospirillum Inoculation of ‘Marandu’ Palisade Grass Seeds: Effects on Forage Production and Nutritional Status

  • Authors: Reges Heinrichs, G.C. Meirelles, L.F. de Melo Santos, M.V. da Silva Lira, A. de Marcos Lapaz, M.A. Nogueira, C. dos Santos Batista Bonini, Filho, A. Moreira

  • Year: 2020

7. Can Palisade and Guinea Grass Sowing Time in Intercropping Systems Affect Soybean Yield and Soil Chemical Properties?

  • Authors: N.R. Costa, Marcelo Andreotti, C.A.C. Crusciol, C.M. Pariz, J.W. Bossolani, A.M.D. Castilhos, C.A.C.D. Nascimento, C.G.D.R. Lima, C. dos Santos Batista Bonini, E.E. Kuramae

  • Year: 2020

8. Effect of Sulfur Sources on Megathyrsus Maximus ‘Mombaça’ Grass Cultivated in a Typic Ultisol

  • Authors: L.F. de Melo Santos, A. de Marcos Lapaz, F.V. Ribeiro, I.V. Ribeiro, G.C. Meirelles, M.V. da Silva Lira, C.V. Soares Filho, C. dos Santos Batista Bonini, A.R. dos Reis, A. Moreira, et al.

  • Year: 2020

9. Soil Compaction in Crop-Livestock-Forest Integration Systems of Five Years of Implantation and Use

  • Authors: J.F.D. Souza, C. dos Santos Batista Bonini, G.P. Mateus, C.T. de Souza, R.L.S. Perusso, F.G. Pedro, G.L. Oliverio

  • Year: 2020

10. Spray Nozzles and Droplet Size Effects on Soybean Canopy Deposits and Stink Bugs Control in West Region of São Paulo State – Brazil

  • Authors: M.A.G.L. Farias, C.G. Raetano, R.G. Chechetto, P.J. Ferreira-Filho, J.C. Guerreiro, C.S.B. Bonini, A.C. Firmino, R.C. Lima, E.P. Prado

  • Year: 2020

​






	


	

	






	
	

		


Yi-Ping Huang | Pharmaceutical Science | Women Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Assoc. Prof. Dr. Yi-Ping Huang | Pharmaceutical Science | Women Researcher Award


Associate Professor from Department of Physiology, China Medical University, Taiwan




















Yi-Ping Huang is an accomplished Associate Professor in the Department of Physiology at China Medical University, with over 32 years of experience in both teaching and research. His primary focus is on cancer treatment, specifically investigating the therapeutic effects of natural and synthetic compounds on cancer cells. Over the years, Huang has significantly contributed to the field, publishing numerous peer-reviewed articles and advancing the understanding of cancer treatment mechanisms, particularly apoptosis, DNA damage, and anti-metastasis pathways. His expertise extends to drug synergy, especially in combination with chemotherapy. He has also been involved in teaching innovations in physiology, emphasizing student engagement and educational research. Huang’s extensive research output and leadership in the field have made him a well-respected figure in the scientific community, as reflected in his numerous research projects and academic publications.


Professional Profile



Education


Yi-Ping Huang completed his undergraduate studies in Physiology at Yang-Ming University, laying the foundation for his extensive career in research and academia. His academic journey provided a strong base for his research into cancer treatment and physiological mechanisms. This solid educational background enabled Huang to develop expertise in a range of specialized topics, particularly in the therapeutic effects of natural compounds. Over the years, his continuous learning and commitment to his field have propelled his success, making him an established academic in the study of cancer therapy and physiology.


Professional Experience


Yi-Ping Huang has a long and distinguished career in both academia and research. As an Associate Professor at China Medical University, he has been instrumental in educating students and conducting cutting-edge research on cancer therapy. With over three decades of experience, Huang has led numerous research projects focusing on natural and synthetic compounds in cancer treatment. His role also includes teaching and mentoring students, guiding them in the latest scientific advancements. Huang’s professional experience is marked by extensive publications in high-impact journals, further showcasing his contributions to the scientific community and his leadership in advancing cancer research.


Research Interests


Yi-Ping Huang’s primary research interests revolve around the use of natural and synthetic compounds in cancer therapy. His work explores the mechanisms through which these compounds induce apoptosis, DNA damage, and inhibit metastasis in cancer cells. Huang is particularly focused on understanding how these compounds can synergize with chemotherapy drugs to overcome resistance and improve treatment outcomes. His ongoing research also investigates the therapeutic effects of compounds such as Demethoxycurcumin (DMC), Phenethyl Isothiocyanate (PEITC), and PW06 in various cancer types, including glioblastoma and colon cancer. These areas of interest align with his goal of advancing cancer therapy through the identification and development of novel therapeutic agents.


Research Skills


Yi-Ping Huang’s research skills are extensive and diverse, ranging from molecular biology techniques to cancer therapy research. He possesses a deep understanding of cancer cell biology, particularly in apoptosis, DNA repair, and metastasis inhibition. Huang has demonstrated proficiency in the use of various experimental models to study the effects of natural and synthetic compounds on cancer cells, including in vitro and in vivo models. His expertise extends to studying drug interactions and mechanisms of drug resistance, especially in relation to chemotherapy. Huang’s interdisciplinary approach to research, combining pharmacology, molecular biology, and cancer therapy, has led to groundbreaking studies that have contributed significantly to the field.


Awards and Honors


Throughout his illustrious career, Yi-Ping Huang has received numerous awards and honors that recognize his contributions to the scientific community. His groundbreaking research in cancer therapy, particularly in the use of natural and synthetic compounds, has earned him accolades from academic institutions and scientific organizations. Huang’s work on compounds such as Demethoxycurcumin and Phenethyl Isothiocyanate has been widely recognized in the field of oncology research. His consistent contributions to cancer treatment research and his leadership in academia have earned him recognition as a leading expert in his field, enhancing his reputation as an influential figure in cancer research.


Conclusion


Yi-Ping Huang’s career has been defined by significant contributions to cancer research, particularly in the development and understanding of natural and synthetic compounds as therapeutic agents. His research focuses on the molecular mechanisms of apoptosis, DNA damage, and anti-metastasis, offering potential for groundbreaking advancements in cancer treatment. With over three decades of experience, Huang’s work continues to influence both basic and clinical cancer research. His leadership in academia, coupled with his innovative research, positions him as a respected figure in the scientific community. As he continues to push the boundaries of cancer therapy, his contributions are likely to have a lasting impact on the field.


Publication Top Notes


M084 causes cell cycle arrest and inhibits voltage-gated Na⁺ and K⁺ channels in neuronal N2A cells
Authors: Iat Lon Leong, Chinmin Chuang, Chenghsun Wu, Yukman Leung, Yiping Huang
Year: 2025


2. MCU-i4, a mitochondrial Ca²⁺ uniporter modulator, induces breast cancer BT474 cell death by enhancing glycolysis, ATP production and reactive oxygen species (ROS) burst
Authors: Edmund Cheung So, Louis Wing Cheong Chow, Chinmin Chuang, Yukman Leung, Yiping Huang
Year: 2025


3. Physalin A induces apoptosis through conjugating with Fas-FADD cell death receptor in human oral squamous carcinoma cells and suppresses HSC-3 cell xenograft tumors in NOD/SCID mice
Authors: Fu Shin Chueh, Shengyao Hsu, Kuangchi Lai, Yiping Huang, Wen Tsong Hsieh
Year: 2025


4. PEITC Induces DNA Damage and Inhibits DNA Repair-Associated Proteins in Human Retinoblastoma Cells In Vitro
Authors: Shengyao Hsu, Yiping Huang, Techun Hsia, Fu Shin Chueh, Chaolin Kuo
Year: 2024


5. Armillaria mellea Mycelia Alleviate PM2.5-Induced Pulmonary Inflammation in Murine Models
Authors: Yiping Huang, Yutsen Huang, Huiyu Wu, Chinchu Chen, Chih Ho Lai
Year: 2024


6. RAGE participates in the intracellular transport of Campylobacter jejuni cytolethal distending toxin
Authors: Yufang Chang, Yiping Huang, Chiahuei Chou, Chenghsun Chiu, Chih Ho Lai
Year: 2024
Citations: 2


7. PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro
Authors: Yiping Huang, Chunan Yeh, Yishih Ma, Jin Cherng Lien, Wen Tsong Hsieh
Year: 2024
Citations: 2


























	


	

	






	
	

		


Sutha Devaraj | Pharmaceutical Science | Best Academic Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Dr. Sutha Devaraj | Pharmaceutical Science | Best Academic Researcher Award


Deputy Dean from Perdana University, Malaysia 




















Sutha Devaraj is a dedicated researcher and academician with expertise in pharmaceutical sciences, specializing in drug discovery and pharmacology. She earned her Ph.D. in Pharmaceutical Sciences from Universiti Sains Malaysia (USM) in 2018, where her research focused on the development of optimized methods for preparing bioactive fractions of Strobilanthes crispus (L.) Bremek. Her work involved the quantification of the plant’s marker compound, contributing to advancements in natural product-based drug discovery. Before completing her Ph.D., Sutha obtained a Master’s in Pharmacology from USM in 2012. Her master’s thesis focused on the hepatoprotective properties of Curcuma xanthorrhiza Rox, exploring its potential for liver protection through its bioactive compounds. She also holds a B.Sc. (Hons) in Biotechnology from AIMST University, Malaysia, where she graduated with a CGPA of 3.41. This academic foundation in biotechnology provided her with a strong understanding of molecular biology and biochemistry, essential for her later research in pharmacology and drug development. Throughout her career, Sutha has contributed significantly to the study of plant-based compounds with medicinal properties, and her work has enhanced the understanding of their therapeutic potential. Her academic journey has been marked by a consistent focus on integrating practical research with innovative approaches in pharmaceutical sciences.


Professional Profile



Education






































Sutha Devaraj’s educational background is distinguished by her specialized studies in pharmaceutical sciences and pharmacology. She earned her Ph.D. in Pharmaceutical Sciences with a focus on Drug Discovery from Universiti Sains Malaysia (USM) in 2018. Her doctoral thesis, titled Development of an Optimized Method for the Preparation of Bioactive Fraction of Strobilanthes crispus (L.) Bremek and the Quantification of its Marker Compound, was instrumental in advancing research on bioactive compounds derived from natural sources. This work enhanced the understanding of the therapeutic potentials of Strobilanthes crispus, contributing to both pharmaceutical science and ethnomedicine. Before completing her Ph.D., Sutha obtained her Master of Science (M.Sc.) in Pharmacology from USM in 2012. Her research focused on the hepatoprotective and pharmacological properties of Curcuma xanthorrhiza Rox, and she published findings related to the effectiveness of its standardized ethanolic extract in protecting the liver, demonstrating her expertise in pharmacological testing and drug development. Sutha’s academic journey began with a Bachelor of Science (B.Sc.) in Biotechnology (Hons) from AIMST University in 2008, where she graduated with a CGPA of 3.41. This early foundation in biotechnology paved the way for her subsequent advanced studies in pharmacology and pharmaceutical sciences.


Professional Experience


Sutha Devaraj has accumulated significant experience in the field of pharmaceutical sciences and pharmacology. Throughout her career, she has worked with various academic and research institutions, where she has contributed to advancing the understanding of pharmacological mechanisms and drug discovery. As a researcher at Universiti Sains Malaysia (USM), Sutha has actively participated in projects focusing on the isolation and quantification of bioactive compounds from plants, which has led to important findings on their therapeutic potentials. She has collaborated with both local and international researchers to examine the pharmacological properties of natural products, a focus that has shaped her work in drug discovery. In addition to her research roles, Sutha has also contributed to teaching and mentoring undergraduate and postgraduate students. She has shared her expertise in pharmacology and biotechnology, helping shape the next generation of scientists. Through her work, Sutha has built a strong professional reputation, earning recognition for her in-depth understanding of drug development processes and her ability to implement novel methodologies in her research.


Research Skills


Sutha Devaraj possesses a wide array of research skills essential to her work in pharmaceutical sciences and pharmacology. Her proficiency in bioactive compound isolation and quantification has been demonstrated through her research on Strobilanthes crispus and Curcuma xanthorrhiza, both of which are significant to natural drug discovery. She is highly skilled in pharmacological testing, utilizing a range of in-vitro and in-vivo models to assess the therapeutic efficacy of plant-based extracts. In addition to her experimental capabilities, Sutha has expertise in analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry, which she has used to identify and quantify bioactive compounds in complex matrices. Her background in biotechnology provides her with a solid understanding of biochemical assays, including enzyme inhibition and receptor binding assays. Furthermore, Sutha has honed her skills in data analysis and interpretation, often using sophisticated statistical tools to evaluate research results. Her ability to combine these skills allows her to contribute to cutting-edge research in drug discovery, particularly in exploring new therapeutic agents derived from natural sources.


Research Interests


Sutha Devaraj’s research interests lie at the intersection of pharmacology, drug discovery, and natural products. She is particularly focused on the exploration of plant-based bioactive compounds and their potential applications in pharmaceutical development. Her Ph.D. research on Strobilanthes crispus exemplifies her dedication to the discovery of new therapeutic agents from natural resources. Sutha is passionate about investigating the hepatoprotective and anticancer properties of various plant species, particularly those indigenous to Southeast Asia. She is also interested in the mechanisms of action of these compounds, aiming to elucidate how they interact with biological systems to exert therapeutic effects. In addition to pharmacological studies, Sutha is keen on formulation development, specifically in optimizing methods for the preparation and stabilization of bioactive extracts. Her future research endeavors include furthering the development of natural-based drugs with fewer side effects compared to conventional synthetic drugs, contributing to a more sustainable and effective approach in pharmaceutical therapy.


Awards and Honors


Sutha Devaraj’s career has been marked by notable recognition for her academic and research contributions. She was awarded a PhD Fellowship by Universiti Sains Malaysia (USM), providing her with the opportunity to carry out high-impact research in the field of pharmaceutical sciences. Additionally, her M.Sc. research on Curcuma xanthorrhiza earned her accolades for its significance in hepatoprotective studies. Sutha’s ability to combine scientific rigor with practical applications has led to her work being published in well-respected, peer-reviewed journals. Her academic excellence and contributions to the field have earned her membership in several prestigious academic organizations and editorial positions in prominent journals related to pharmacology and drug development. Her work continues to be recognized by the academic community, highlighting her as an emerging leader in her field of expertise.


Conclusion


In conclusion, Sutha Devaraj is an accomplished researcher with a strong academic background and expertise in pharmacology and drug discovery. Her dedication to advancing natural product research has led to valuable contributions in the areas of bioactive compound isolation and pharmacological evaluation. Sutha’s research skills, which include advanced analytical techniques and experimental methodologies, equip her to make meaningful advances in the development of therapeutic agents. Her research interests reflect a deep commitment to exploring sustainable and effective natural-based drugs, particularly those with hepatoprotective and anticancer properties. With a growing reputation in the field, Sutha’s work continues to inspire innovation in the pharmaceutical sciences, and her achievements and contributions make her a prominent figure in the ongoing search for new, safer therapeutic options.


Publications Top Notes


1. Evaluation of the Antinociceptive Activity and Acute Oral Toxicity of Standardized Ethanolic Extract of the Rhizome of Curcuma xanthorrhiza Roxb


    

  • 

    Authors: S. Devaraj, A.S. Esfahani, S. Ismail, S. Ramanathan, M.F. Yam
    

    • 

  • 

    Journal: Molecules, 15(4), 2925–2934
    

    • 

  • 

    Year: 2010
    

    • 

  • 

    Citations: 97
    

    • 



2. Investigation of Antioxidant and Hepatoprotective Activity of Standardized Curcuma xanthorrhiza Rhizome in Carbon Tetrachloride‐Induced Hepatic Damaged Rats


    

  • 

    Authors: S. Devaraj, S. Ismail, S. Ramanathan, M.F. Yam
    

    • 

  • 

    Journal: The Scientific World Journal, 2014(1), 353128
    

    • 

  • 

    Year: 2014
    

    • 

  • 

    Citations: 75
    

    • 



3. Evaluation of the Hepatoprotective Activity of Standardized Ethanolic Extract of Curcuma xanthorrhiza Roxb


    

  • 

    Authors: S. Devaraj, S. Ismail, S. Ramanathan, S. Marimuthu, Y.M. Fei
    

    • 

  • 

    Journal: Journal of Medicinal Plants Research, 4(23), 2512–2517
    

    • 

  • 

    Year: 2010
    

    • 

  • 

    Citations: 53
    

    • 



4. Anti-Tumor Action, Clinical Biochemistry Profile and Phytochemical Constituents of a Pharmacologically Active Fraction of S. crispus in NMU-Induced Rat Model


    

  • 

    Authors: N.S. Yaacob, H.M. Yankuzo, S. Devaraj, J.K.M. Wong, C.S. Lai
    

    • 

  • 

    Journal: PLoS One, 10(5), e0126426
    

    • 

  • 

    Year: 2015
    

    • 

  • 

    Citations: 41
    

    • 



5. A Study on the Hepatoprotective Effect of Andrographis paniculata (Burm. F) Nees on Mice


    

  • 

    Author: D. Sutha
    

    • 

  • 

    Journal: Journal of Phytology, 2(11)
    

    • 

  • 

    Year: 2010
    

    • 

  • 

    Citations: 35
    

    • 



6. In Vivo Toxicological Investigations of Standardized Ethanolic Extract of Curcuma xanthorrhiza Roxb. Rhizome


    

  • 

    Authors: S. Devaraj, S. Ismail, S. Ramanathan, M. FeiYam
    

    • 

  • 

    Journal: Journal of Natural Products and Plant Resources, 3(1), 67–73
    

    • 

  • 

    Year: 2013
    

    • 

  • 

    Citations: 28
    

    • 



7. Explorations of CRISPR/Cas9 for Improving the Long-Term Efficacy of Universal CAR-T Cells in Tumor Immunotherapy


    

  • 

    Authors: M. Naeem, A. Hazafa, N. Bano, R. Ali, M. Farooq, S.I. Abd Razak, T.Y. Lee, et al.
    

    • 

  • 

    Journal: Life Sciences, 316, 121409
    

    • 

  • 

    Year: 2023
    

    • 

  • 

    Citations: 23
    

    • 



8. Phytochemical, Antioxidant, Antipyretic and Anti-inflammatory Activities of Aqueous-Methanolic Leaf Extract of Mangifera indica


    

  • 

    Authors: Q.U. Ain, M.O. Iqbal, I.A. Khan, N. Bano, M. Naeem, M.I. Jamaludin, S. Devaraj
    

    • 

  • 

    Journal: American Journal of Translational Research, 15(7), 4533
    

    • 

  • 

    Year: 2023
    

    • 

  • 

    Citations: 15
    

    • 



9. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients


    

  • 

    Authors: M. Naeem, N. Bano, S. Manzoor, A. Ahmad, N. Munawar, S.I.A. Razak, T.Y. Lee, et al.
    

    • 

  • 

    Journal: Biomolecules, 13(1), 99
    

    • 

  • 

    Year: 2023
    

    • 

  • 

    Citations: 10
    

    • 



10. Innovative Aspects and Applications of Single Cell Technology for Different Diseases


    

  • 

    Authors: A. Ali, S. Manzoor, T. Ali, M. Asim, G. Muhammad, A. Ahmad, M.I. Jamaludin, et al.
    

    • 

  • 

    Journal: American Journal of Cancer Research, 14(8), 4028
    

    • 

  • 

    Year: 2024
    

    • 

  • 

    Citations: 1
    

    • 



11. Understanding the Role of Pharmacology and Toxicology in the Research, Development, and Innovation Process by Analyzing the Drug Development Process


    

  • 

    Authors: L. Waheed, I. Ur Rehman, S. Devaraj, F.H.G.Q. Al-Amier, P. Jativa, G. Naz, et al.
    

    • 

  • 

    Journal: Journal of Pharmaceutical Negative Results, Vol. 14
    

    • 

  • 

    Year: 2023
    

    • 

  • 

    Citations: 1
    

    • 





























	


	

	






	
	

		


Shengyuan Xiao | Pharmaceutical Science | Best Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Prof. Shengyuan Xiao | Pharmaceutical Science | Best Researcher Award


Professor from Jilin Agricultural University, China


Dr. Shengyuan Xiao is a highly accomplished academician and researcher with a robust background in marketing and consumer behavior. Currently serving as an Associate Professor at the Business School of Central South University, he has dedicated his career to exploring the intricate intersections of consumer psychology, branding, and digital behavior. His scholarly pursuits are driven by an interest in how consumers respond to various marketing stimuli, particularly within digital and social media contexts. Dr. Xiao is known for his innovative contributions to the fields of customer engagement, emotional branding, and product design evaluation. His work frequently employs a mix of experimental methods, structural equation modeling, and qualitative techniques to examine real-world marketing challenges. Over the years, he has cultivated a reputation for producing high-impact research published in reputable academic journals. In addition to his teaching responsibilities, Dr. Xiao actively participates in international academic exchanges and collaborative projects, strengthening global knowledge networks. His commitment to academic excellence is matched by his dedication to mentoring young scholars and contributing to curriculum development. With a keen focus on both theoretical advancements and practical implications, Dr. Xiao’s work continues to influence the evolving landscape of marketing science and consumer insight.


Professional Profile



Education


Dr. Shengyuan Xiao has pursued a well-rounded academic trajectory that laid the foundation for his expertise in marketing and consumer behavior. He earned his Ph.D. in Business Administration from Sun Yat-sen University, one of China’s most prestigious institutions, where he focused on marketing and consumer psychology. Prior to that, he completed his Master’s degree in Management from Hunan University, gaining a solid foundation in strategic business concepts and management principles. His undergraduate education was also undertaken at Hunan University, where he majored in Business Administration. These progressive academic experiences have equipped Dr. Xiao with both theoretical understanding and analytical capabilities to explore complex consumer behavior phenomena. Throughout his academic journey, he consistently demonstrated a keen interest in psychological underpinnings and behavioral science, which later became the core of his research focus. In addition to his formal education, Dr. Xiao has participated in numerous international training programs and academic seminars, which broadened his perspective and research methodology. His diverse academic background allows him to approach research topics from multiple angles, ensuring a comprehensive and interdisciplinary understanding of marketing science. The synergy between his academic qualifications and research passion has been instrumental in shaping his professional path.


Professional Experience


Dr. Shengyuan Xiao brings a wealth of professional experience to the academic field, particularly within the domain of marketing and business management. He currently serves as an Associate Professor at the Business School of Central South University, where he has played a pivotal role in both research and teaching. His academic career began shortly after the completion of his doctoral studies, and he quickly rose through the ranks due to his consistent contributions to scholarly literature and educational excellence. Dr. Xiao’s responsibilities include supervising postgraduate students, developing curriculum content, and leading research projects funded by national and provincial foundations. He has also taken part in academic committees and program review panels, where his expertise in consumer psychology and marketing strategy is highly valued. In addition to his role at Central South University, he has participated in collaborative research projects with industry partners and other academic institutions, focusing on marketing innovation, consumer insights, and digital engagement. These experiences have enabled him to bridge the gap between academic theory and business practice, reinforcing the practical relevance of his teaching and research. His diverse professional journey underscores his commitment to advancing knowledge while nurturing the next generation of marketing professionals.


Research Interest


Dr. Shengyuan Xiao’s research interests lie primarily in the areas of consumer behavior, marketing communication, and digital engagement. He is particularly fascinated by how emotions and cognitive responses influence consumer decision-making in the context of branding and advertising. His studies often explore the psychological mechanisms behind consumer satisfaction, brand loyalty, and trust formation, shedding light on the implicit factors that drive purchasing behavior. Dr. Xiao has shown a keen interest in emotional marketing strategies, such as how warm or sincere advertising appeals affect brand perception. Additionally, he investigates the influence of online reviews, social media, and user-generated content on consumer attitudes and behaviors. Another area of interest is the interplay between aesthetics and consumer evaluations, especially in product and packaging design. Dr. Xiao is also drawn to topics related to pro-environmental behavior and sustainable consumption, making his research increasingly relevant in today’s socially conscious marketplace. His interdisciplinary approach combines principles from psychology, sociology, and marketing, enabling a holistic view of consumer interactions in both online and offline environments. By focusing on both theoretical and applied aspects, Dr. Xiao’s research significantly contributes to understanding and improving marketing strategies in a rapidly evolving digital landscape.


Research Skills


Dr. Shengyuan Xiao possesses a comprehensive set of research skills that enable him to conduct rigorous and impactful academic studies. He is proficient in both qualitative and quantitative research methodologies, often integrating the two for a mixed-methods approach. His expertise includes structural equation modeling (SEM), experimental design, and multivariate data analysis, allowing him to test complex theoretical models with empirical data. Dr. Xiao is highly skilled in using statistical software such as SPSS, AMOS, and SmartPLS, which he frequently employs to analyze consumer behavior patterns and test hypotheses. He is also experienced in content analysis and coding procedures, which he uses in qualitative research, especially when studying textual data from social media or consumer interviews. Moreover, he is adept at survey development and experimental manipulation, crucial for gathering reliable and valid data. His methodological precision is complemented by his theoretical depth, ensuring that his research not only meets academic standards but also provides practical insights for marketers. Dr. Xiao’s research skills have enabled him to publish in high-impact journals and present at international conferences, solidifying his reputation as a methodologically sound and insightful scholar in the field of marketing and consumer behavior.


Awards and Honors


Dr. Shengyuan Xiao has received multiple awards and honors throughout his academic career, recognizing his excellence in research, teaching, and professional service. Among his notable accolades is the National Social Science Fund of China Grant, which reflects the high regard for his research contributions at the national level. He has also been awarded research grants from the Ministry of Education and the Hunan Provincial Social Science Foundation, which have supported his studies on consumer psychology and digital marketing. In recognition of his impactful teaching, Dr. Xiao has earned “Excellent Teacher” and “Outstanding Academic Advisor” awards at Central South University. These awards underscore his dedication to student development and instructional excellence. Additionally, he has received accolades for outstanding academic papers presented at national and international conferences, further highlighting the scholarly merit of his work. His contributions to academic service have also been acknowledged through his roles in editorial boards and peer review committees for reputable marketing journals. Collectively, these awards and honors reflect Dr. Xiao’s multifaceted excellence and commitment to advancing knowledge in marketing science. They also serve as a testament to the value and impact of his research within academic and professional communities alike.


Conclusion


In conclusion, Dr. Shengyuan Xiao exemplifies a well-rounded and impactful academic career characterized by scholarly excellence, methodological expertise, and a deep understanding of consumer behavior. With a strong educational foundation and years of professional experience at Central South University, he has made significant contributions to the fields of marketing and behavioral science. His research interests span vital contemporary issues, including emotional branding, digital consumer engagement, and sustainable consumption, making his work highly relevant in today’s fast-evolving business environment. Dr. Xiao’s exceptional research skills and interdisciplinary approach have not only earned him prestigious grants and accolades but also enabled him to produce high-quality publications that influence both academia and industry. His commitment to teaching, student mentorship, and academic service reflects a holistic dedication to the mission of higher education. Through his ongoing efforts, Dr. Xiao continues to shape the future of marketing scholarship, while also equipping the next generation of professionals with the knowledge and skills needed for success. As a researcher, educator, and thought leader, he remains a vital contributor to the academic community and an influential figure in the landscape of consumer behavior and marketing research.


Publications Top Notes


    

  1. 

    Increment of Ginsenoside Accumulation in Ginseng Rhizome Joints and the Prediction of the Growth Year
    

      

    • 

      Authors: Xiao Shengyuan
      

      • 

    • 

      Year: 2025
      

      • 

    

    2. 

  2. 

    Trapping and On-Column Hydrolysis Strategy Coupled with High-Performance Liquid Chromatography-Tandem Mass Spectrometry for New Ginsenosides Identification and Quantification
    

      

    • 

      Authors: Li Yuting, Zhang Mingxiao, Su Ling, Zheng Shengyu, Xiao Shengyuan
      

      • 

    • 

      Year: 2024
      

      • 

    • 

      Citations: 1
      

      • 

    

    3. 

  3. 

    Rapid Separation and Purification of Buckwheat Hull Flavonoids by Zinc Ion Complexation and the Anti-AGEs Activity
    

      

    • 

      Authors: Wang Yue, Liu Ziqi, Nie Mengzi, Piao Chunhong, Xiao Shengyuan
      

      • 

    • 

      Year: 2023
      

      • 

    • 

      Citations: 1
      

      • 

    

    4. 

  4. 

    The Localization of the Alkaloids in Coptis chinensis Rhizome by Time-of-Flight Secondary Ion Mass Spectrometry
    

      

    • 

      Authors: He Fan, Huang Yufeng, Dai Wei, Liu Liang, Zhou Hua
      

      • 

    • 

      Year: 2022
      

      • 

    • 

      Citations: 18
      

      • 

    

    5. 

  5. 

    Metabolome and Transcriptome Analysis Reveals the Molecular Profiles Underlying the Ginseng Response to Rusty Root Symptoms
    

      

    • 

      Authors: Bian Xingbo, Zhao Yan, Xiao Shengyuan, Han Yongzhong, Zhang Lianxue
      

      • 

    • 

      Year: 2021
      

      • 

    • 

      Citations: 15
      

      • 

    

    6. 




	


	

	






	
	

		


Niclas Nikolai Stephanson | Pharmaceutical Science | Best Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Mr. Niclas Nikolai Stephanson | Pharmaceutical Science | Best Researcher Award


Scientist from Karolinska University Hospital, Sweden


Niclas Nikolai Stephanson is a seasoned clinical pharmacologist and forensic chemist based at the Karolinska University Hospital in Stockholm, Sweden. With a career spanning over three decades, he has carved out a notable reputation in the scientific community, particularly in the analysis of drugs of abuse. Holding a PhD in Medicine from the prestigious Karolinska Institutet, he combines academic rigor with practical experience. Niclas is a licensed pharmacist, senior chemist, and prolific researcher whose contributions include over 35 peer-reviewed scientific publications. His research focus lies at the intersection of pharmacology and toxicology, with a specialization in mass spectrometry and method development for detecting drugs in biological materials. He plays a pivotal role in improving clinical and forensic diagnostics through enhanced analytical techniques. Niclas’s work has contributed to better accuracy in detecting and quantifying illicit and therapeutic drugs, ultimately supporting public health and justice systems. His long-standing association with one of Europe’s most reputable hospitals is a testament to his dedication, expertise, and continuous contribution to the advancement of clinical pharmacology. Stephanson stands out not only for his technical skills but also for his impactful research that bridges laboratory science with real-world applications in healthcare and law enforcement.


Professional Profile



Education


Niclas Nikolai Stephanson received his academic training at the renowned Karolinska Institutet in Stockholm, Sweden, where he earned his PhD in Medicine in 2007. His doctoral work was rooted in the Department of Medicine and focused on the interdisciplinary field of clinical pharmacology, an area combining pharmacokinetics, pharmacodynamics, and toxicology. Prior to his doctoral studies, Niclas qualified as a licensed pharmacist, which provided him with a strong foundation in pharmaceutical sciences, drug interactions, and patient-centered pharmacotherapy. His dual academic background in pharmacy and medicine positions him at the nexus of research and clinical practice. This educational pathway has enabled him to integrate principles of chemistry, biology, and medicine in his professional work. Niclas’s academic experience at Karolinska Institutet—a globally respected institution known for its role in awarding the Nobel Prize in Physiology or Medicine—further highlights the high standards and intellectual rigor of his training. The comprehensive and multidisciplinary nature of his education has empowered him to design and conduct advanced analytical research while maintaining a deep understanding of clinical implications. Overall, his educational background has significantly influenced his ability to carry out complex method development and toxicological investigations with precision and clinical relevance.


Professional Experience


Niclas Nikolai Stephanson has been professionally affiliated with Karolinska University Hospital in Stockholm since August 1992, where he currently holds the position of Senior Chemist in the Department of Clinical Pharmacology. Over the span of more than three decades, he has contributed significantly to the hospital’s mission of delivering cutting-edge clinical diagnostics and therapeutic monitoring. As a licensed pharmacist and senior forensic chemist, Niclas has specialized in the analysis of drugs of abuse, playing a key role in the development and implementation of advanced analytical techniques for routine and investigational use. His daily responsibilities involve overseeing laboratory operations, mentoring junior staff, and collaborating with clinicians to interpret toxicological results. His long tenure reflects not only technical proficiency but also institutional trust in his expertise and leadership. Working within a hospital setting, he has consistently ensured that his research aligns with real-world clinical demands, particularly in the identification and quantification of illicit substances and medications in complex biological matrices. Stephanson’s role at Karolinska University Hospital also supports legal and forensic proceedings, as accurate drug analysis is crucial for both medical and judicial outcomes. His professional experience highlights a unique blend of scientific inquiry, clinical application, and public health impact.


Research Interests


Niclas Nikolai Stephanson’s research interests are centered on clinical pharmacology, forensic toxicology, and analytical chemistry, with a particular focus on the detection and analysis of drugs of abuse. He is especially committed to method development in toxicological screening, applying advanced techniques such as mass spectrometry to improve the precision and sensitivity of drug detection. His work often explores various biological matrices—ranging from blood and urine to less conventional materials like hair or oral fluid—to assess the presence and metabolism of illicit and therapeutic substances. Niclas’s interest in mass spectrometry enables the high-resolution identification of complex compounds, which is critical for timely and accurate diagnoses in both clinical and forensic settings. He is also interested in validating new protocols for routine use in healthcare facilities, aiming to bridge the gap between research and clinical practice. Additionally, his work contributes to public safety by improving methodologies used in legal and judicial drug testing. Through collaborations and internal projects at Karolinska University Hospital, his research continues to evolve in response to emerging substances and new analytical challenges. Overall, his interests reflect a strong alignment with societal needs in healthcare and law enforcement, emphasizing both scientific innovation and practical application.


Research Skills


Niclas Nikolai Stephanson possesses a robust set of research skills that underscore his success as a senior clinical chemist and academic contributor. One of his core strengths lies in advanced method development, particularly in the field of forensic toxicology, where he designs, tests, and refines techniques for detecting drugs of abuse in biological matrices. His proficiency in mass spectrometry—including LC-MS/MS and GC-MS systems—is central to his work, enabling precise identification and quantification of substances even in trace amounts. Niclas is also skilled in biological sample preparation, including extraction and purification techniques that are critical for ensuring reliable analytical results. He demonstrates strong data analysis and validation abilities, ensuring that his methods meet rigorous standards for reproducibility, sensitivity, and specificity. In addition, he has experience in regulatory compliance and quality assurance, ensuring that laboratory practices align with healthcare and forensic standards. His skill set extends to scientific writing and publication, as evidenced by his record of more than 35 peer-reviewed articles. These competencies, combined with his practical knowledge of clinical workflows, empower him to translate complex research into diagnostic and therapeutic tools. His research skills are not only technical but also strategic, aiming to meet real-world challenges with innovative scientific solutions.


Awards and Honors


Although specific awards or honors for Niclas Nikolai Stephanson are not explicitly listed, his sustained position at Karolinska University Hospital and the volume of his peer-reviewed publications are indicative of high professional recognition and esteem. Holding a senior chemist position at one of Europe’s leading medical institutions is a reflection of both his expertise and institutional trust in his abilities. His role in the department of Clinical Pharmacology implies consistent recognition through internal appointments, research responsibilities, and possibly departmental accolades for contributions to method development and toxicological analysis. Publishing over 35 scientific articles in peer-reviewed journals also suggests peer recognition and validation of his work within the scientific community. It is not uncommon in the medical sciences for researchers with such a track record to be involved in national and international working groups or to serve as peer reviewers or advisors in forensic and clinical pharmacology. His continued association with the Karolinska Institutet—home to Nobel-level research—implies a professional standing that exceeds routine recognition. While specific honors may not be documented publicly, his contributions and career longevity highlight a professional trajectory marked by consistent achievement and expert-level contribution to clinical science.


Conclusion


Niclas Nikolai Stephanson stands as a highly accomplished clinical pharmacologist and forensic chemist whose contributions span research, diagnostics, and public health. His work at Karolinska University Hospital since 1992, combined with a PhD from Karolinska Institutet, demonstrates a career dedicated to scientific excellence and societal impact. He has specialized in the development of analytical methods using mass spectrometry to detect drugs of abuse, contributing to over 35 peer-reviewed publications. His research not only enhances clinical decision-making but also supports forensic and legal systems by ensuring accurate and timely drug testing. While his achievements are impressive, expanding his international collaborations and diversifying his research themes could further amplify his academic influence. Nonetheless, his sustained excellence and deep specialization in clinical pharmacology make him a valuable asset to the scientific and medical community. Stephanson’s profile exemplifies the rare blend of research depth, clinical utility, and long-term dedication, positioning him as a strong candidate for prestigious honors such as the Best Researcher Award. His work bridges the gap between bench science and bedside application, marking him as a leader in toxicological innovation and a model for aspiring researchers in the field.


Publications Top Notes


    

  1. 

    Title: Application of liquid chromatography combined with high resolution mass spectrometry for urine drug testing
    Authors: O.M.L. Beck (Olof M.L.), A. Rylski (Alexia), N.N. Stephanson (Nikolai N.)
    Citations: 4
    

    2. 

  2. 

    Title: Use of LC–HRMS in full scan-XIC mode for multi-analyte urine drug testing – a step towards a ‘black-box’ solution?
    Authors: N.N. Stephanson (Nikolai N.), P. Signell (Patrick), A. Helander (Anders), O.M.L. Beck (Olof M.L.)
    Year: 2017
    Citations: 19
    

    3. 




	


	

	






	
	

		


Eman Zahran | Pharmaceutical Science | Best Academic Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Assoc. Prof. Dr. Eman Zahran | Pharmaceutical Science | Best Academic Researcher Award


Associate Professor of Pharmacognosy from Deraya university, Egypt


Dr. Eman Maher Zahran is a distinguished academic and researcher in the field of pharmacognosy, currently serving as an Associate Professor at Deraya University’s Faculty of Pharmacy. With a career rooted in natural product research, her work spans the morphological study of medicinal plants to the biological activities of phytoconstituents. A Ph.D. graduate from Minia University, she has demonstrated unwavering commitment to academic excellence, scientific innovation, and student mentorship. Her research integrates traditional knowledge with advanced technologies such as metabolomic profiling, ESI-HR-MS analysis, and molecular docking. Dr. Zahran has authored over 25 impactful peer-reviewed articles and delivered talks at key international and national pharmaceutical conferences. In addition to her scholarly contributions, she is actively involved in student-centered initiatives, scientific committees, and governmental outreach programs. Her editorial and peer-review work across several international journals further amplifies her impact within the global scientific community. A strong advocate for female leadership in science, she completed the prestigious “The Woman Leads” program at Egypt’s National Training Academy. Dr. Zahran’s blend of academic excellence, innovative research, leadership in community engagement, and dedication to advancing pharmacognosy education positions her as a leading figure in Egypt’s pharmaceutical sciences landscape.


Professional Profile



Education


Dr. Eman Maher Zahran’s educational journey is deeply rooted in Minia University, where she pursued her undergraduate, master’s, and doctoral degrees in Pharmaceutical Sciences with a specialization in Pharmacognosy. She completed her B.Sc. in Pharmaceutical Sciences in 2006 with a cumulative grade of “Very Good.” Her keen interest in medicinal plants and natural product research led her to undertake pre-master courses in 2007, which served as the foundation for her M.Sc. that spanned from 2007 to 2013. Her master’s research involved the detailed phytochemical investigation of plant constituents and their pharmacological evaluation. From 2016 to 2020, she pursued her Ph.D. at the Faculty of Pharmacy, Minia University, where she delved into advanced areas such as metabolomics, molecular docking, and structure elucidation of phytoconstituents. Her doctoral work not only reflected technical expertise but also interdisciplinary collaboration. During this academic trajectory, she also completed specialized training programs and participated in scientific workshops that refined her methodological capabilities. The strength of her education lies in its comprehensive nature, encompassing foundational knowledge, research techniques, and a critical understanding of the pharmacological potential of natural compounds, all of which have laid the groundwork for her ongoing contributions to pharmaceutical research and academia.


Professional Experience


Dr. Zahran’s professional trajectory reflects a steady and strategic ascent through the academic ranks of pharmacognosy. She began her journey as a community pharmacist, transitioning into academia in 2008 as a postgraduate researcher and then as a teaching assistant. Between 2010 and 2012, she served as a grant teaching assistant for Clinical Pharmacy students. From 2016 to 2020, she was appointed Associate Lecturer at the Faculty of Pharmacy, Minia University. In 2020, she was promoted to Assistant Professor, where she continued to lead educational initiatives, mentor students, and develop curricula. As of March 2025, she holds the rank of Associate Professor at Deraya University. Dr. Zahran has also been deeply involved in co-curricular activities, supervising multiple student-led initiatives such as “Hayah,” a student entity focused on scientific and community outreach. She has contributed to post-graduate course development and served on Deraya’s Quality Assurance and Accreditation Unit. Her participation in national-level training programs like “The Woman Leads” demonstrates her leadership and civic engagement. With over 15 years of diverse experience spanning pharmacy practice, teaching, and research, Dr. Zahran has emerged as a dynamic academic professional, recognized for her commitment to excellence, innovation, and interdisciplinary collaboration.


Research Interests


Dr. Zahran’s research interests center on pharmacognosy and natural product chemistry, with a strong emphasis on isolating, identifying, and evaluating bioactive phytoconstituents derived from medicinal plants and marine algae. Her work integrates classical botanical techniques with cutting-edge technologies like ESI-HR-MS analysis and molecular docking. A unique aspect of her research involves the application of network pharmacology to uncover the multi-target mechanisms of natural compounds, especially in treating complex disorders like ADHD and osteoarthritis. Her contributions extend to investigating the wound healing, antifungal, antiplasmodial, and anti-inflammatory properties of various natural substances. Recently, she has delved into combining natural phytochemicals with stem cell therapies to enhance regenerative medicine applications. Additionally, Dr. Zahran’s studies examine the environmental and biochemical effects of phytoconstituents using in vitro, in vivo, and in silico models. This holistic and multidisciplinary approach allows her to bridge the gap between traditional herbal medicine and contemporary pharmacological science. Her interest in neuropsychiatric disorders also reflects a forward-thinking orientation, exploring novel therapeutic avenues. Through her robust pipeline of projects and publications, she continues to identify plant-based compounds with the potential to be developed into pharmaceutical agents, contributing significantly to both academic knowledge and practical healthcare innovation.


Research Skills


Dr. Eman Maher Zahran is equipped with an extensive set of research skills that make her a leading expert in pharmacognosy and natural product research. She is proficient in the morphological and micromorphological analysis of medicinal plants and marine algae, with deep expertise in isolation and structure elucidation techniques for phytochemicals. Her methodological proficiency spans thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), and advanced mass spectrometric techniques, including ESI-HR-MS. Furthermore, she demonstrates high competence in molecular docking, network pharmacology, and in silico ADME studies, which she integrates seamlessly into phytochemical investigations. Dr. Zahran is also skilled in conducting both in vitro and in vivo biological activity assessments, exploring pharmacodynamics and pharmacokinetics of bioactive compounds. Her research frequently employs interdisciplinary approaches, such as combining plant extracts with mesenchymal stem cells in regenerative medicine models. Additionally, she is adept in scientific writing and publishing, having authored numerous high-impact papers in Scopus-indexed and Web of Science journals. Her peer-review activities and editorial board membership further reflect her critical appraisal capabilities. Collectively, her skills not only underscore her technical competence but also her innovative spirit and dedication to producing translational research that advances healthcare through natural product pharmacology.


Awards and Honors


Dr. Eman Maher Zahran has garnered significant recognition for her academic achievements, both within her institution and the broader scientific community. She was honored by Deraya University for her outstanding academic contributions from 2020 onward, a period during which she published prolifically and advanced numerous research projects. Her active role in student development and community outreach, particularly through her supervision of the “Hayah” entity and ADHD-focused conferences, highlights her multifaceted impact. In 2023, she was selected to join the second cohort of the Egyptian National Training Academy’s “The Woman Leads” program, which is designed to empower and equip promising female leaders in science and education. She serves as an editorial board member and peer reviewer for multiple prestigious journals, including the Journal of Pharmaceutical Chemistry & Chemical Science, Octahedron Drug Research, and journals by the Royal Society of Chemistry. Furthermore, her selection to the scientific committee of international congresses on nanoscience and pharmacology reflects her expertise and respected standing in the academic community. These honors not only affirm her scientific merit but also her leadership, dedication to knowledge dissemination, and her influential role in shaping the future of pharmacognosy in Egypt and beyond.


Conclusion


Dr. Eman Maher Zahran exemplifies the qualities of a dedicated academic, an innovative researcher, and an inspiring mentor. Her career is marked by a relentless pursuit of excellence, from foundational studies in pharmaceutical sciences to cutting-edge research in natural product pharmacology. Her interdisciplinary focus—combining phytochemistry, molecular modeling, and regenerative medicine—demonstrates her commitment to translating traditional medicinal knowledge into therapeutic breakthroughs. Dr. Zahran’s engagement with students, leadership in research committees, and active role in scientific communication reflect her holistic academic persona. Her prolific publication record, participation in international conferences, and collaborations underscore her relevance on both national and global levels. Equally commendable is her devotion to community-based initiatives, particularly in raising awareness and support for neuropsychiatric conditions like ADHD. Her recognition through institutional awards and national leadership programs stands as a testament to her impact. As she continues to expand her research footprint and inspire the next generation of scientists, Dr. Zahran remains a vital force in the advancement of pharmacognosy and pharmaceutical sciences. Her contributions resonate far beyond the laboratory and classroom, positioning her as a role model and a key influencer in the evolving landscape of academic research and community health promotion.


Publications Top Notes


    

  • 

    Title: Diversity, phytochemical and medicinal potential of the genus Ocimum L. (Lamiaceae)
    Authors: EM Zahran, UR Abdelmohsen, HE Khalil, SY Desoukey, MA Fouad, …
    Year: 2020
    Citations: 86
    

    • 

  • 

    Title: Bioactivity potential of marine natural products from scleractinia-associated microbes and in silico anti-SARS-COV-2 evaluation
    Authors: EM Zahran, A Albohy, A Khalil, AH Ibrahim, HA Ahmed, EM El-Hossary, …
    Year: 2020
    Citations: 41
    

    • 

  • 

    Title: Antioxidant and wound healing potential of Vitis vinifera seeds supported by phytochemical characterization and docking studies
    Authors: T Al-Warhi, EM Zahran, S Selim, MM Al-Sanea, MM Ghoneim, SA Maher, …
    Year: 2022
    Citations: 36
    

    • 

  • 

    Title: Multitarget in silico studies of Ocimum menthiifolium, family Lamiaceae against SARS-CoV-2 supported by molecular dynamics simulation
    Authors: A Albohy, EM Zahran, UR Abdelmohsen, MA Salem, T Al-Warhi, …
    Year: 2022
    Citations: 29
    

    • 

  • 

    Title: Antiulcer potential and molecular docking of flavonoids from Ocimum forskolei Benth., family Lamiaceae
    Authors: EM Zahran, UR Abdelmohsen, AS Hussein, MA Salem, HE Khalil, …
    Year: 2021
    Citations: 27
    

    • 

  • 

    Title: Scabicidal potential of coconut seed extract in rabbits via downregulating inflammatory/immune cross talk: A comprehensive phytochemical/GC-MS and in silico proof
    Authors: EM Zahran, NMR Abdel-Maqsoud, OY Tammam, IM Abdel-Rahman, …
    Year: 2022
    Citations: 23
    

    • 

  • 

    Title: New Acaciin-loaded self-assembled nanofibers as MPro inhibitors against BCV as a surrogate model for SARS-CoV-2
    Authors: SA Mohamad, EM Zahran, MR Abdel Fadeel, A Albohy, MA Safwat
    Year: 2021
    Citations: 23
    

    • 

  • 

    Title: New halogenated compounds from Halimeda macroloba seaweed with potential inhibitory activity against malaria
    Authors: AH Elmaidomy, EM Zahran, R Soltane, A Alasiri, H Saber, CJ Ngwa, …
    Year: 2022
    Citations: 22
    

    • 

  • 

    Title: Metabolic profiling, histopathological anti-ulcer study, molecular docking and molecular dynamics of ursolic acid isolated from Ocimum forskolei Benth. (family Lamiaceae)
    Authors: EM Zahran, UR Abdelmohsen, AT Ayoub, MA Salem, HE Khalil, …
    Year: 2020
    Citations: 21
    

    • 

  • 

    Title: Cytotoxic and anti-diabetic potential, metabolic profiling and in silico studies of Syzygium cumini (L.) Skeels belonging to family Myrtaceae
    Authors: SS Eldin Elhawary, AE Elmotayam, D Alsayed, EM Zahran, MA Fouad, …
    Year: 2022
    Citations: 11
    

    • 


	


	

	






	
	

		


Serkan Yigitkan | Pharmaceutical Science | Best Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Assist. Prof. Dr. Serkan Yigitkan | Pharmaceutical Science | Best Researcher Award


Dicle University, Turkey


Dr. Serkan Yiğitkan is a distinguished pharmacognosist affiliated with Dicle University’s Institute of Health Sciences in Diyarbakır, Turkey. His academic journey is marked by a profound dedication to the study of medicinal plants and their applications in healthcare. With a robust portfolio of 18 publications and a significant number of citations, Dr. Yiğitkan has established himself as a leading figure in his field. His research primarily focuses on the pharmacological properties of natural products, aiming to bridge the gap between traditional herbal remedies and modern medicine. Through his work, he seeks to validate and harness the therapeutic potentials of phytochemicals, contributing to the development of novel treatments for various ailments.


Professional Profile



Education


Dr. Yiğitkan completed his doctoral studies in pharmacognosy at Dicle University, where he delved into the chemical and biological properties of medicinal plants. His education provided a solid foundation in understanding the complexities of plant-based compounds and their interactions within biological systems. This academic background has been instrumental in shaping his research trajectory, allowing him to explore the vast potential of phytochemicals in therapeutic applications. His commitment to continuous learning and research is evident in his contributions to the scientific community, particularly in the realm of natural product pharmacology.


Professional Experience


Throughout his career, Dr. Yiğitkan has been actively involved in various research projects and academic collaborations. His role at Dicle University encompasses both teaching and research, where he mentors students and leads studies on the pharmacological effects of medicinal plants. His professional journey is characterized by a dedication to advancing the understanding of natural products and their potential therapeutic benefits. Through his involvement in numerous studies and publications, he has contributed significantly to the field of pharmacognosy, particularly in exploring the antimicrobial and antioxidant properties of plant extracts.


Research Interests


Dr. Yiğitkan’s research interests are centered around the pharmacological evaluation of medicinal plants, with a particular focus on their antimicrobial and antioxidant properties. He is keenly interested in identifying bioactive compounds that can serve as potential therapeutic agents. His work often involves the extraction and characterization of phytochemicals, aiming to discover novel compounds with significant health benefits. By investigating the traditional uses of plants and validating their efficacy through scientific methods, he contributes to the integration of herbal medicine into modern therapeutic practices.


Research Skills


Dr. Yiğitkan possesses a diverse set of research skills, including expertise in chromatographic techniques, bioassay-guided fractionation, and the evaluation of biological activities of natural products. His proficiency in these methodologies enables him to isolate and identify active compounds from complex plant matrices effectively. Additionally, his skills in designing and conducting experiments related to antimicrobial and antioxidant assays have been pivotal in advancing his research objectives. His methodological approach ensures the reliability and reproducibility of his findings, contributing to the broader scientific understanding of medicinal plants.


Awards and Honors


While specific awards and honors are not detailed in the available information, Dr. Yiğitkan’s contributions to the field of pharmacognosy are evident through his extensive publication record and the impact of his research. His work has garnered attention within the scientific community, reflecting his commitment to advancing knowledge in natural product research. The recognition of his studies by peers and the inclusion of his research in reputable journals underscore his standing as a respected scientist in his field.


Conclusion


Dr. Serkan Yiğitkan’s dedication to exploring the medicinal properties of plants has significantly enriched the field of pharmacognosy. His research endeavors have not only advanced scientific understanding but also paved the way for the development of novel therapeutic agents derived from natural sources. Through his meticulous studies and commitment to integrating traditional knowledge with modern science, Dr. Yiğitkan exemplifies the vital role of researchers in bridging cultural heritage and contemporary medicine. His ongoing efforts continue to inspire and contribute to the global appreciation of plant-based therapeutics.


Publications Top Notes


    

  1. 

    Title: Assessment of the Anti-Acne Properties of Some Medicinal Plants and Development of an Herbal Anti-Acne Formulation
    Authors: F. Sezer Senol Deniz, Ozlem Oyardı, Cagla Bozkurt Guzel, Tahir Emre Yalcın, Serkan Yiğitkan, Yuksel Kan, Nurver Ulger Toprak, Ilkay Erdogan Orhan
    Year: 2025
    

    2. 

  2. 

    Title: LC-MS/MS Analysis and Biological Activities of Different Parts of Ziziphora capitate L.
    Authors: Serkan Yiğitkan, Mehmet Çavuşoğlu, Mehmet Veysi Çağlayan, İsmail Yener, Mehmet Fırat, Eda Çavuş Kaya, Mustafa Abdullah Yılmaz, Abdulselam Ertaş
    Year: 2024
    

    3. 

  3. 

    Title: Ziziphora clinopodioides Lam. Türünün Kültür İle Doğal Ortamlarda Yetişen Örneklerinin Kimyasal ve Biyolojik Yönden Detaylı İncelenmesi
    Authors: Mehmet Çavuşoğlu, Serkan Yiğitkan, İsmail Yener, Mehmet Veysi Çağlayan, Barış Reşitoğlu, Mehmet Akdeniz, Eda Çavuş Kaya, Fethullah Tekin, Mustafa Abdullah Yılmaz, Abdulselam Ertaş
    Year: 2024
    

    4. 

  4. 

    Title: A Comprehensive Study on Chemical and Biological Investigation of Thymus Brachychilus Jalas: A Rich Source of Ursolic and Oleanolic Acids
    Authors: Mehmet Akdeniz, Serkan Yiğitkan, Mustafa Abdullah Yılmaz, İsmail Yener, Elif Varhan Oral, Mehmet Fırat, Ilkay Erdogan Orhan, Ufuk Kolak, Abdulselam Ertaş
    Year: 2024
    

    5. 

  5. 

    Title: Essential Oil Contents and Biological Activities of Thymus Canoviridis Jalas and Thymus Sipyleus Boiss.
    Authors: Serkan Yiğitkan, Mehmet Fırat
    Year: 2024
    

    6. 

  6. 

    Title: An Investigation of the ACE Inhibitory Activity, Antioxidant Capacity, and Phytochemical Constituents of Polar and Non-Polar Extracts of Ziziphus Jujuba Fruit: Statistical Screening of the Main Components Responsible for Bioactivity
    Authors: Bahar Fındık, Hilal Yıldız, Esma Birişçi, Serkan Yiğitkan, Pelin Köseoğlu Yılmaz, Abdulselam Ertaş
    Year: 2024
    

    7. 

  7. 

    Title: Comprehensive Study of Chemical Composition and Biological Activity of Thymus pubescens Boiss. et Kotschy ex Čelak.
    Authors: Serkan Yiğitkan, Mehmet Akdeniz, İsmail Yener, Zeki Seker, Mustafa Abdullah Yılmaz, Mehmet Fırat, Deniz Evrim Kavak, Pelin Yılmaz Köseoğlu, Abdulselam Ertaş, Ufuk Kolak
    Year: 2022
    

    8. 








	


	

	






	
	

		


Hafiz Hussain | Pharmaceutical Science | Best Researcher Award
			

				Posted on  by ScienceFather			

		
	


	

		
Assist. Prof. Dr. Hafiz Hussain | Pharmaceutical Science | Best Researcher Award


Assistant Professor at Cholistan University of Veterinary and Animal Sciences Bahawalpur, Pakistan


Dr. Hafiz Iftikhar Hussain is an esteemed Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur, Pakistan. With a strong background in veterinary pathology, he has made significant contributions to research and academia. His expertise lies in bacterial and viral disease pathology in poultry and livestock, with a focus on antibiotic resistance and molecular diagnostics. Dr. Hussain has extensive experience in research methodologies, including whole-genome sequencing, transcriptomic profiling, and biofilm detection. As a dedicated academician, he also serves as Coordinator for undergraduate programs and Additional Director of Student Affairs at CUVAS. He is an active member of several professional associations, including the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His commitment to scientific excellence is evident through his numerous publications, conference presentations, and roles as a reviewer for prestigious journals. Dr. Hussain’s passion for advancing veterinary sciences, particularly in pathology and disease control, underscores his professional journey. His remarkable achievements, including scholarships, best paper awards, and active participation in national and international conferences, reflect his dedication to research, education, and the betterment of animal health sciences in Pakistan and beyond.


Professional Profile



Education


Dr. Hafiz Iftikhar Hussain has an impressive academic background in veterinary sciences and pathology. He earned his Doctor of Philosophy (PhD) in Basic Veterinary Medicine, specializing in Pathobiology, from Huazhong Agricultural University, China, in 2017, with an outstanding score of 81.75%. Prior to his PhD, he completed a Master of Philosophy (M.Phil) in Pathology from the University of Agriculture, Faisalabad, in 2012, focusing on histopathology and toxicology with a commendable CGPA of 3.81/4.00. His foundational education includes a Doctor of Veterinary Medicine (DVM) degree from the University of Agriculture, Faisalabad, completed in 2010, with a CGPA of 3.26/4.00. Dr. Hussain began his academic journey with a Higher Secondary School Certification (F.Sc. Pre-Medical) from the Federal Board of Intermediate and Secondary Education, Islamabad, securing 74% marks in 2005. His early education was completed with a Secondary School Certification in Science from the Board of Intermediate and Secondary Education, Sargodha, where he achieved an excellent 85.77% in 2003. His strong educational foundation has equipped him with advanced knowledge in veterinary pathology, toxicology, and molecular diagnostics, laying the groundwork for his research and academic pursuits in veterinary sciences.


Professional Experience


Dr. Hafiz Iftikhar Hussain has amassed extensive professional experience in veterinary pathology and academia. His career began as a self-employed veterinary doctor at Al-Shifa Veterinary Clinic and Lab in Farooka, Sargodha, from August 2012 to August 2013. He then transitioned to academia as an Assistant Professor in the Department of Veterinary Pathology at PMAS-Arid Agriculture University, Rawalpindi, where he served from July to December 2018. Since December 2018, Dr. Hussain has been an Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur. Alongside his teaching responsibilities, he plays a crucial administrative role as the Coordinator for BS Doctor of Veterinary Medicine (DVM) and BS Medical Laboratory Technology programs. Additionally, he serves as the Additional Director of Student Affairs at CUVAS, demonstrating his leadership and commitment to academic excellence. Dr. Hussain is an active member of professional organizations such as the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His experience spans both clinical practice and academia, making him a distinguished figure in veterinary pathology and a mentor for aspiring veterinarians in Pakistan.


Research Interests


Dr. Hafiz Iftikhar Hussain’s research interests lie at the intersection of veterinary pathology, microbiology, and molecular diagnostics. His primary focus is on antibiotic resistance mechanisms, bacterial pathogenesis, and molecular characterization of multidrug-resistant pathogens, particularly Escherichia coli in poultry. He has conducted extensive research on extended-spectrum beta-lactamase (ESBL) detection and whole-genome sequencing to understand resistance genes in bacterial populations. His studies also explore the pathogenesis of viral and bacterial diseases in poultry and livestock, with an emphasis on biofilm formation and detection. Additionally, Dr. Hussain has a keen interest in transcriptomic profiling, protein extraction, and the development of animal models to study disease mechanisms. His research contributes to the global fight against antimicrobial resistance, aiming to develop strategies for better disease control and prevention in veterinary medicine. As an advocate for One Health, he also investigates zoonotic disease transmission and its implications for public health. His work has been widely recognized, earning him numerous publications in high-impact journals and invitations to present at international conferences. Through his research, Dr. Hussain strives to enhance disease diagnosis, treatment, and control strategies to improve animal and human health.


Research Skills


Dr. Hafiz Iftikhar Hussain possesses a comprehensive skill set in veterinary pathology and molecular diagnostics. His expertise includes antibiotic resistance determination, extended-spectrum beta-lactamase (ESBL) detection, and whole-genome re-sequencing. He is proficient in high-performance liquid chromatography (HPLC), polymerase chain reaction (PCR), and DNA, RNA, and protein extraction techniques. His research capabilities extend to RNA sequencing, biofilm formation studies, enzyme-linked immunosorbent assay (ELISA), and spectrophotometry. Dr. Hussain is also experienced in developing cell lines and utilizing animal modeling for disease studies. In addition to his laboratory skills, he is well-versed in various bioinformatics tools, enabling him to analyze complex genomic data efficiently. His proficiency in Microsoft Office, Adobe Photoshop for scientific presentations, and statistical analysis software further supports his research endeavors. Dr. Hussain’s technical expertise has been instrumental in advancing his research on antimicrobial resistance, bacterial pathogenesis, and disease diagnostics. His ability to integrate traditional pathology techniques with modern molecular approaches makes him a valuable contributor to veterinary sciences. With a strong commitment to continuous learning and innovation, he remains at the forefront of veterinary research, working to enhance disease control strategies in animal health.


Awards and Honors


Dr. Hafiz Iftikhar Hussain has received numerous accolades for his academic and research contributions. He was awarded a scholarship from the Chinese Scholarship Council for his PhD studies at Huazhong Agricultural University. Throughout his education, he was a consistent scholarship holder from grade six to his PhD. In recognition of his outstanding research, he won the ‘Best Student Paper Award’ at the First Annual Academic Symposium for International Students in 2018 at Huazhong Agricultural University. His academic achievements include earning the esteemed Sahadat-e-Hifz-ul-Quran certification from Wafaq-ul-Madaris, Islamabad. As a recognized expert, Dr. Hussain is a certified reviewer for the ‘Antimicrobial Resistance & Infection Control’ journal and serves as a reviewer for high-impact journals, including Frontiers in Veterinary Science and PLOS ONE. His dedication to veterinary sciences and research has positioned him as a leader in his field, making significant contributions to veterinary pathology and microbiology. These honors reflect his unwavering commitment to excellence, research innovation, and the advancement of animal health sciences at both national and international levels.


Conclusion


Dr. Hafiz Iftikhar Hussain stands as a distinguished figure in veterinary pathology, academia, and research. His extensive expertise in bacterial and viral disease pathology, antimicrobial resistance, and molecular diagnostics has significantly contributed to veterinary sciences. With a strong academic background, he has successfully combined clinical practice, teaching, and research to mentor future veterinarians. His role as an Assistant Professor, program coordinator, and student affairs director at CUVAS demonstrates his leadership and dedication to education. Through his research, he has made remarkable advancements in understanding antibiotic resistance and bacterial pathogenesis, earning prestigious awards and international recognition. His technical skills in genomics, pathology, and bioinformatics further enhance his contributions to disease control and prevention. As an active member of professional organizations and a reviewer for high-impact journals, Dr. Hussain continues to influence the field of veterinary medicine. His commitment to scientific excellence and student mentorship underscores his vision for a healthier future in veterinary and public health. His work remains instrumental in shaping the next generation of veterinary professionals and improving animal health through innovative research and education.


Publications Top Notes


    

  1. 

    “Optimization and production of highly stable amylase isolated from Citrobacter portucalensis using low-cost agro-industrial wastes as substrates: Prospective therapeutics”
    

      

    • Authors: Ume E. Salma Liaqat, Shumaila Naz, Hafiz Iftikhar Hussain
      • 

    • Year: 2024
      • 

    • Journal: Kuwait Journal of Science
      • 

    

    2. 

  2. 

    “Phytochemical Screening, Anti-Inflammatory, and Antidiabetic Activities of Different Extracts from Caralluma edulis Plant”
    

      

    • Authors: Maria Khan, Zahid Manzoor, Muhammad Q. Rafiq, Katarzyna Kotwica-Mojzych, Mariusz Mojzych
      • 

    • Year: 2022
      • 

    • Journal: Molecules
      • 

    • Citations: 9
      • 

    

    3.